Here is where you can learn all about the latest BioLegend news and upcoming events.
PerkinElmer, Inc. announced it has entered into an agreement to acquire BioLegend, a leading, global provider of life science antibodies and reagents.
Gene Lay, founder, president and chief executive officer of BioLegend, said “We are very excited to join the PerkinElmer family. The combination will afford us the opportunity to continue to build on our two-decade foundation of innovative science and scale in new and highly attractive PerkinElmer areas such as clinical diagnostics and food safety testing. The BioLegend team is eager to enter this new chapter with PerkinElmer, furthering our mission of enabling legendary discovery from research to cure.”
See all of the BioLegend news articles >>
We love the opportunity to meet our customers online and in-person. Let’s connect virtually or at a local event near you.
It is also an excellent opportunity to learn about how we can partner together to accelerate your research. We also love to hear your feedback about how we’re doing and how are products are performing in your lab. Let’s connect at a local event near you.
See our lineup of upcoming events >>